Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer
- PMID: 29720122
- PMCID: PMC5930854
- DOI: 10.1186/s12885-018-4420-8
Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer
Abstract
Background: Dickkopf-1 (DKK1) is a Wnt/ß-catenin pathway antagonist related to gastric cancer (GC) carcinogenesis. However, the prognostic role of combined DKK1 and ß-catenin expression in advanced GC (AGC) is not clear.
Methods: In total, 158 patients with AGC who underwent gastric resection were enrolled in this study. DKK1 and ß-catenin expression was evaluated in whole tumor sections by immunohistochemistry.
Results: DKK1 expression was high in 73 (46.2%) patients, while ß-catenin expression was positive in 51 (32.3%) patients. The expression of DKK1 was positively correlated with that of ß-catenin (P < 0.001). The combined expression of DKK1 and ß-catenin was significantly associated with high N stage (N2 and N3) (P = 0.042). In addition, patients with high DKK expression demonstrated poorer overall (OS) (P < 0.001) and disease-free survival (DFS) (P = 0.001). However, there were no differences between high DKK1 expression with ß-catenin positivity and high DKK1 expression with ß-catenin negativity (OS, P = 0.379: DFS, P = 0.255). Multivariate analysis revealed that high DKK1 alone or high DKK1 with ß-catenin positivity were independent prognostic factors for both OS (high DKK1: hazard ratio [HR], 2.130; 95% confidence interval [CI]; 1.370-3.312, P = 0.001; high DKK1 with ß-catenin positivity: HR, 2.140; 95% CI, 1.343-3.409: P = 0.001) and DFS (high DKK1: HR, 2.092; 95% CI, 1.180-3.708; P = 0.012; high DKK1 with ß-catenin positivity: HR, 2.357; 95% CI, 1.291-4.306; P = 0.005).
Conclusion: Our results indicate that high DKK1 expression regardless of ß-catenin positivity is a crucial prognostic factor for predicting tumor recurrence and survival in patients with resected AGC.
Keywords: Cut value; Dickkopf-1; Gastric cancer; Prognosis.
Conflict of interest statement
Authors’ information
Soon Auck Hong: Clinical Assistant Professor, Department of Pathology, Soonchunhyang Cheonan University Hospital, Cheonan, Republic of Korea.
Soo Hyun Yoo: Pathologist, Medical Clinic Laboratory Department of U2Bio Co. Ltd., Seoul, Republic of Korea.
Han Hong Lee: Associate Professor, Department of General Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Der Sheng Sun: Clinical Associate Professor, Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Hye Sung Won: Associate Professor, Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Okran Kim: Researcher, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Yoon Ho Ko: Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea and Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Ethics approval and consent to participate
This study was approved by the Institutional Research Ethics Board of Uijeongbu St. Mary’s Hospital of the Catholic University of Korea. Due to the retrospective nature of the study and the fact that no identifiable information is included, informed consent was not required according to laws of the Institutional Research Ethics Board of Uijeongbu St. Mary’s Hospital of the Catholic University of Korea. The project was compliance with the Helsinki Declaration.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer.Sci Rep. 2022 Feb 4;12(1):1931. doi: 10.1038/s41598-022-05914-4. Sci Rep. 2022. PMID: 35121803 Free PMC article.
-
The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.Diagn Pathol. 2015 Jul 28;10:128. doi: 10.1186/s13000-015-0356-3. Diagn Pathol. 2015. PMID: 26215716 Free PMC article.
-
Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9. J Hepatol. 2009. PMID: 19303159
-
Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.World J Gastroenterol. 2014 Sep 14;20(34):12313-21. doi: 10.3748/wjg.v20.i34.12313. World J Gastroenterol. 2014. PMID: 25232267 Free PMC article. Review.
-
Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8312-21. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674197 Free PMC article. Review.
Cited by
-
PFT-α protects the blood-brain barrier through the Wnt/β-catenin pathway after acute ischemic stroke.Funct Integr Genomics. 2023 Sep 30;23(4):314. doi: 10.1007/s10142-023-01237-3. Funct Integr Genomics. 2023. PMID: 37777676
-
A comprehensive insight into the correlation between ncRNAs and the Wnt/β-catenin signalling pathway in gastric cancer pathogenesis.Cell Commun Signal. 2023 Jun 29;21(1):166. doi: 10.1186/s12964-023-01092-6. Cell Commun Signal. 2023. PMID: 37386429 Free PMC article. Review.
-
Reciprocal Regulation of Cancer-Associated Fibroblasts and Tumor Microenvironment in Gastrointestinal Cancer: Implications for Cancer Dormancy.Cancers (Basel). 2023 Apr 27;15(9):2513. doi: 10.3390/cancers15092513. Cancers (Basel). 2023. PMID: 37173977 Free PMC article. Review.
-
Propofol-Induced miR-493-3p Inhibits Growth and Invasion of Gastric Cancer through Suppression of DKK1-Mediated Wnt/β-Catenin Signaling Activation.Dis Markers. 2023 Jan 31;2023:7698706. doi: 10.1155/2023/7698706. eCollection 2023. Dis Markers. 2023. PMID: 36762306 Free PMC article.
-
A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction model.Mol Ther Nucleic Acids. 2022 Dec 27;31:224-240. doi: 10.1016/j.omtn.2022.12.014. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2022. PMID: 36700042 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
